The Impact of Homogeneous Versus Heterogeneous Emphysema on Dynamic Hyperinflation in Patients with Severe COPD Assessed for Lung Volume Reduction

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 12, Issue 6, 2015, Pages 598-605

  Boutou, Afroditi K ^a   Zoumot, Zaid ^a,b   Nair, Arjun ^a   Davey, Claire ^a   Hansell, David M ^a   Jamurtas, Athanasios ^c   Polkey, Michael I ^a   Hopkinson, Nicholas S ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b HEART AND VASCULAR INSTITUTE   (United Arab Emirates)

^c UNIVERSITY OF THESSALY   (Greece)

Author keywords

chronic obstructive pulmonary disease

Indexed keywords

ADULT; ARTICLE; BREATHING RATE; CARDIOPULMONARY EXERCISE TEST; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DYNAMIC HYPERINFLATION; EMPHYSEMA; FEMALE; FORCED EXPIRATORY VOLUME; HETEROGENEOUS EMPHYSEMA; HOMOGENEOUS EMPHYSEMA; HUMAN; HYPERINFLATION; INSPIRATORY CAPACITY; LUNG EMPHYSEMA; LUNG FUNCTION TEST; LUNG INJURY; LUNG MINUTE VOLUME; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TIDAL VOLUME; TOTAL LUNG CAPACITY; AGED; EXERCISE TEST; LUNG RESECTION; MIDDLE AGED; PATHOPHYSIOLOGY; PATIENT SELECTION; PULMONARY EMPHYSEMA; X-RAY COMPUTED TOMOGRAPHY;

AGED; EXERCISE TEST; FEMALE; HUMANS; LUNG VOLUME MEASUREMENTS; MALE; MIDDLE AGED; PATIENT SELECTION; PNEUMONECTOMY; PULMONARY EMPHYSEMA; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84951573497     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2015.1020149     Document Type: Article

References (43)

1. Ferguson GT. Why does the lung hyperinflate? Proc Am Thorac Soc. 2006; 3 (2): 176-179.
2. O'Donnell DE. Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006; 3 (2): 180-184.
3. Tzani P, Aiello M, Elia D, Boracchia L, Marangio E, Olivieri D, Clini E, Chetta A. Dynamic hyperinflation is associated with a poor cardiovascular response to exercise in COPD patients. Respir Res 2011; 12 (1): 150.
4. Zafar MA, Tsuang W, Lach L, Eschenbacher W, Panos RJ. Dynamic hyperinflation correlates with exertional oxygen desaturation in patients with chronic obstructive pulmonary disease. Lung 2013; 191 (2): 177-182.
5. Coxson HO. Quantitative chest tomography in COPD research: chairman's summary. Proc Am Thorac Soc 2008; 5 (9): 874-877.
6. Stolk J, Versteegh MIM, Montenij LJ, Bakker ME, Grebski E, Tutic M, Wildermuth S, Weder W, el Bardiji M, Reiber JH, Rabe KF, Russi EW, Stoel BC. Densitometry for assessment of effect of lung volume reduction surgery for emphysema. Eur Respir J 2007; 29 (6): 1138-1143.
7. Gould GA, Redpath AT, Ryan M, Warren PM, Best JJ, Flenley DC, MacNee W. Lung CT density correlates with measurements of airflow limitation and the diffusing capacity. Eur Respir J 1991; 4 (2): 141-146.
8. Müller NL, Staples CA, Miller RR, Abboud RT. "Density mask". An objective method to quantitate emphysema using computed tomography. Chest 1988; 94 (4): 782-787.
9. Mair G, Miller JJ, McAllister D, Maclay J, Connell M, Murchison J T, MacNee W. Computed tomographic emphysema distribution: relationship to clinical features in a cohort of smokers. Eur Respir J 2009; 33 (3): 536-542.
10. McNulty W, Zoumot Z, Hopkinson NS. Bronchoscopic and percutaneous approaches to lung volume reduction. Clin Pulm Med 2013; 20 (6): 300-308.
11. Murphy PB, Zoumot Z, Polkey MI. Noninvasive ventilation and lung volume reduction. Clin Chest Med 2014; 35 (1): 251-269.
12. Sanchez PG, Kucharczuk JC, Su S, Kaiser LR, Cooper JD. National Emphysema Treatment Trial redux: accentuating the positive. J Thorac Cardiovasc Surg 2010; 140 (3): 564-572.
13. McKenna RJ Jr, Brenner M, Fischel RJ, Singh N, Yoong B, Gelb AF, Osann KE. Patient selection criteria for lung volume reduction surgery. J Thorac Cardiovasc Surg 1997; 114 (6): 957-964; discussion 964-967.
14. De Torres JP, Bastarrika G, Zagaceta J, Sáiz-Mendiguren R, Alcaide AB, Seijo LM, Campo A, Zuluetta JJ. Emphysema presence, severity, and distribution has little impact on the clinical presentation of a cohort of patients with mild to moderate COPD. Chest 2011; 139 (1): 36-42.
15. Clark SJ, Zoumot Z, Bamsey O, Polkey MI, Dusmet M, Lim E, Jordn S, Hopkinson NS. Surgical approaches for lung volume reduction in emphysema. Clin Med Lond 2014; 14 (2): 122-127.
16. Shah PL, Zoumot Z, Singh S, Bicknell SR, Ross ET, Quiring J, Hopkinson NS, Kemp SV,; RESET trial Study Group. Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trial. Lancet Respir Med 2013; 1 (3): 233-240.
17. Davey C, Zoumot Z, Jordan S, Carr DH, Polkey MI, Shah PL, Hopkinson NS. Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (The BeLieVeR-HIFi trial): study design and rationale. Thorax 2014 Mar 24; doi: 10.1136/thoraxjnl-2014-205127. [Epub ahead of print]
18. Zoumot Z, Kemp SV, Caneja C, Singh S, Shah PL. Bronchoscopic intrabullous autologous blood instillation: a novel approach for the treatment of giant bullae. Ann Thorac Surg 2013; 96 (4): 1488-1491.
19. Zavorsky GS, Cao J, Mayo NE, Gabbay R, Murias JM. Arterial versus capillary blood gases: a meta-analysis. Respir Physiol Neurobiol 2007; 155 (3): 268-279.
20. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16: 5-40.
21. Clark EH, Woods RL, Hughes JM. Effect of blood transfusion on the carbon monoxide transfer factor of the lung in man. Clin Sci Mol Med 1978; 54 (6): 627-631.
22. Gierada DS, Yusen RD, Pilgram TK, Crouch L, Slone RM, Bae KT, Lefrak SS, Cooper JD. Repeatability of quantitative CT indexes of emphysema in patients evaluated for lung volume reduction surgery. Radiology 2001; 220 (2): 448-454.
23. Gevenois PA, de Maertelaer V, De Vuyst P, Zanen J, Yernault JC. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1995; 152 (2): 653-657.
24. Gietema HA, Müller NL, Fauerbach PVN, Sharma S, Edwards LD, Camp PG, et al. Quantifying the extent of emphysema: factors associated with radiologists estimations and quantitative indices of emphysema severity using the ECLIPSE cohort. Acad Radiol 2011; 18 (6): 661-671.
25. Wang Z, Gu S, Leader JK, Kundu S, Tedrow JR, Sciurba FC, Gur D, Siegfried JM, Pu J. Optimal threshold in CT quantification of emphysema. Eur Radiol 2013; 23 (4): 975-984.
26. Gierada DS, Slone RM, Bae KT, Yusen RD, Lefrak SS, Cooper JD. Pulmonary emphysema: comparison of preoperative quantitative CT and physiologic index values with clinical outcome after lung-volume reduction surgery. Radiology 1997; 205 (1): 235-242.
27. National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung volume reduction surgery. N Engl J Med 2001; 345 (15): 1075-1083.
28. American Thoracic Society, American College of Chest Physicians. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003; 167 (2): 211-277.
29. Wasserman K. Principles of Exercise Testing and Interpretation: Including Pathophysiology and Clinical Applications. Lippincott Williams & Wilkins, Philadelphia, PA; 2005. 620 p.
30. Beaver WL, Wasserman K, Whipp BJ. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 1986; 60 (6): 2020-2027.
31. Guenette JA, Chin RC, Cory JM, Webb KA, O'Donnell DE. Inspiratory Capacity during exercise: measurement, analysis, and interpretation. Pulm Med 2013; 2013: 956081
32. Russi EW, Bloch KE, Weder W. Functional and morphological heterogeneity of emphysema and its implication for selection of patients for lung volume reduction surgery. Eur Respir J 1999; 14 (1): 230-236.
33. Weder W, Thurnheer R, Stammberger U, Bürge M, Russi EW, Bloch KE. Radiologic emphysema morphology is associated with outcome after surgical lung volume reduction. Ann Thorac Surg 1997; 64 (2): 313-319
34. Hopkinson NS, Kemp SV, Toma TP, Hansell DM, Geddes DM, Shah PL, Polkey MI. Atelectasis and survival after bronchoscopic lung volume reduction for COPD. Eur Respir J 2011; 37 (6): 1346-1351.
35. Puente-Maestu L, Stringer WW. Hyperinflation and its management in COPD. Int J Chron Obstruct Pulmon Dis 2006; 1 (4): 381-400.
36. Gagnon P, Guenette JA, Langer D, Laviolette L, Mainguy V, Maltais F, Ribeiro F, Saei D. Pathogenesis of hyperinflation in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2014; 9: 187-201.
37. O'Donnell DE, Laveneziana P. The clinical importance of dynamic lung hyperinflation in COPD. COPD 2006; 3 (4): 219-232.
38. Maltais F, Hamilton A, Marciniuk D, Hernandez P, Sciurba FC, Richter K, Kesten S, O'Donnell D. Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest. 2005; 128 (3): 1168-1178.
39. Hopkinson NS, Toma TP, Hansell DM, Goldstraw P, Moxham J, Geddes DM, Polkey MI. Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema. Am J Respir Crit Care Med 2005; 171 (5): 453-460.
40. O'Donnell DE, Lam M, Webb KA. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158 (5 Pt 1): 1557-1565.
41. Vassaux C, Torre-Bouscoulet L, Zeineldine S, Cortopassi F, Paz-Díaz H, Celli BR, Pinto-Plata VM. Effects of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD. Eur Respir J 2008; 32 (5): 1275-1282.
42. Miller JD, Pegelow DF, Jacques AJ, Dempsey JA. Effects of augmented respiratory muscle pressure production on locomotor limb venous return during calf contraction exercise. J Appl Physiol 2005; 99 (5): 1802-1815.
43. Montes de Oca M, Rassulo J, Celli BR. Respiratory muscle and cardiopulmonary function during exercise in very severe COPD. Am J Respir Crit Care Med 1996; 154 (5): 1284-1289.